Role of NADPHox/Rho-kinase signaling in the cyclosporine-NSAIDs interactions on blood pressure and baroreflexes in female rats

Life Sciences

Volumn 185, Issue , 2017, Pages 15-22

  El Gowelli, Hanan M ^a   Ibrahim, Karim S ^a   El Yazbi, Ahmed F ^a,b   El Mas, Mahmoud M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Arterial baroreceptors; Blood pressure; Cyclosporine; NADPHoxidase; Nonsteroidal antiinflammatory drugs; Rho kinase

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOSPORIN A; DICLOFENAC; DIPHENYLIODONIUM SALT; FASUDIL; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CYCLOSPORIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CHRONOTROPISM; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; ENZYME INHIBITION; FEMALE; HEART RATE; HYPERTENSION; NONHUMAN; PRESSORECEPTOR REFLEX; RAT; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG INTERACTION; METABOLISM; WISTAR RAT;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BAROREFLEX; BLOOD PRESSURE; CELECOXIB; CYCLOSPORINE; DICLOFENAC; DRUG INTERACTIONS; FEMALE; HYPERTENSION; NADPH OXIDASE; PHENYLEPHRINE; RATS; RATS, WISTAR; RHO-ASSOCIATED KINASES;

EID: 85025458132     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2017.07.019     Document Type: Article

References (56)

1. Cole, E.H., Prasad, G.V., Cardella, C.J., Kim, J.S., Tinckam, K.J., Cattran, D.C., Schiff, J.R., Landsberg, D.N., Zaltzman, J.S., Gill, J.S., A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients. Transp. Res., 2, 2013, 1, 10.1186/2047-1440-2-1.
2. Ash, Z., Gaujoux-Viala, C., Gossec, L., Hensor, E.M., FitzGerald, O., Winthrop, K., van der Heijde, D., Emery, P., Smolen, J.S., Marzo-Ortega, H., A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis. Ann. Rheum. Dis. 71 (2012), 319–326, 10.1136/ard.2011.150995.
3. Kisiel, B., Kruszewski, R., Juszkiewicz, A., Raczkiewicz, A., Bachta, A., Tłustochowicz, M., Staniszewska-Varga, J., Kłos, K., Duda, K., Bogusławska-Walecka, R., Płoski, R., Tłustochowicz, W., Methotrexate, cyclosporine a, and biologics protect against atherosclerosis in rheumatoid arthritis. J Immunol Res, 2015, 2015, 759610, 10.1155/2015/759610.
4. El-Mas, M.M., El-Gowelli, H.M., Abd-Elrahman, K.S., Saad, E.I., Abdel-Galil, A.G., Abdel-Rahman, A.A., Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function. Biochem. Pharmacol. 81 (2011), 526–533, 10.1016/j.bcp.2010.11.013.
5. Nasser, S.A., Elmallah, A.I., Sabra, R., Khedr, M.M., El-Din, M.M., El-Mas, M.M., Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions. Eur. J. Pharmacol. 727 (2014), 52–59, 10.1016/j.ejphar.2014.01.034.
6. Wissing, K.M., Pipeleers, L., Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment. Transplant. Rev. (Orlando) 28 (2014), 37–46, 10.1016/j.trre.2013.12.004.
7. El-Mas, M.M., Mohy El-Din, M.M., Helmy, M.M., Omar, A.G., Redox imbalances incite the hypertensive, baroreflex, and autonomic effects of cyclosporine in rats. Eur. J. Pharmacol. 694 (2012), 82–88, 10.1016/j.ejphar.2012.08.021.
8. Lees, P., Giraudel, J., Landoni, M.F., Toutain, P.L., PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology. J. Vet. Pharmacol. Ther. 27 (2004), 491–502.
9. Goltsov, A., Maryashkin, A., Swat, M., Kosinsky, Y., Humphery-Smith, I., Demin, O., Goryanin, I., Lebedeva, G., Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations. Eur. J. Pharm. Sci. 36 (2009), 122–136, 10.1016/j.ejps.2008.10.015.
10. Fournier, J.P., Sommet, A., Bourrel, R., Oustric, S., Pathak, A., Lapeyre-Mestre, M., Montastruc, J.L., Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. Eur. J. Clin. Pharmacol. 68 (2012), 1533–1540, 10.1007/s00228-012-1283-9.
11. Varga, Z., Kriška, M., Kristová, V., Petrová, M., Analysis of non-steroidal anti-inflammatory drug use in hospitalized patients and perception of their risk. Interdiscip. Toxicol. 6 (2013), 141–144, 10.2478/intox-2013-0022.
12. Chen, H.I., Chapleau, M.W., McDowell, T.S., Abboud, F.M., Prostaglandins contribute to activation of baroreceptors in rabbits. Possible paracrine influence of endothelium. Circ. Res. 67 (1990), 1394–1404.
13. Snitsarev, V., Whiteis, C.A., Chapleau, M.W., Abboud, F.M., Neuronal prostacyclin is an autocrine regulator of arterial baroreceptor activity. Hypertension 46 (2005), 540–546.
14. Cavalcante, E.G., Aikawa, N.E., Lozano, R.G., Lotito, A.P., Jesus, A.A., Silva, C.A., Chronic polyarthritis as the first manifestation of juvenile systemic lupus erythematosus patients. Lupus 20 (2011), 960–964, 10.1177/0961203311400113.
15. Deray, G., Le Hoang, P., Aupetit, B., Achour, A., Rottembourg, J., Baumelou, A., Enhancement of cyclosporine A nephrotoxicity by diclofenac. Clin. Nephrol. 27 (1987), 213–214.
16. Altman, R.D., Perez, G.O., Sfakianakis, G.N., Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis. Am. J. Med. 93 (1992), 396–402.
17. Olyaei, A.J., de Mattos, A.M., Bennett, W.M., Immunosuppressant-induced nephropathy: pathophysiology, incidence and management. Drug Saf. 21 (1999), 471–488.
18. El-Mas, M.M., Helmy, M.W., Ali, R.M., El-Gowelli, H.M., Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling. Toxicol. Appl. Pharmacol. 284 (2015), 1–7, 10.1016/j.taap.2015.01.018.
19. Helmy, M.W., El-Gowelli, H.M., Ali, R.M., El-Mas, M.M., Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats. Br. J. Pharmacol. 172 (2015), 4291–4302, 10.1111/bph.13199.
20. Forman, H.J., Redox signaling: an evolution from free radicals to aging. Free Radic. Biol. Med. S0891–5849:16 (2016), 30323–30329, 10.1016/j.freeradbiomed.2016.07.003.
21. Yoshioka, K., Sugimoto, N., Takuwa, N., Takuwa, Y., Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2 +-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. Mol. Pharmacol. 71 (2007), 912–920.
22. Martinez, L.L., Oliveira, M.A., Miguel, A.S., Rastelli, V.M., Cruz, J.W., Tostes, R.C., Carvalho, M.H., Nigro, D., Fortes, Z.B., Losartan attenuates the antimigratory effect of diclofenac in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 46 (2005), 190–199.
23. Martinez, L.L., Oliveira, M.A., Miguel, A.S., Rastelli, V.M., Walber, J., Cruz, M.C., Tostes, R.C., Carvalho, M.H., Nigro, D., Fortes, Z.B., Enalapril interferes with the effect of diclofenac on leucocyte-endothelium interaction in hypertensive rats. J. Cardiovasc. Pharmacol. 43 (2004), 258–265.
24. Fouda, M.A., El-Gowelli, H.M., El-Gowilly, S.M., Rashed, L., El-Mas, M.M., Impairment of nitric oxide synthase but not heme oxygenase accounts for baroreflex dysfunction caused by chronic nicotine in female rats. PLoS One, 9, 2014, e98681, 10.1371/journal.pone.0098681 (eCollection 2014).
25. Smyth, H.S., Sleight, P., Pickering, G.W., Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ. Res. 24 (1969), 109–121.
26. Kono, H., Rusyn, I., Uesugi, T., Yamashina, S., Connor, H.D., Dikalova, A., Mason, R.P., Thurman, R.G., Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 280 (2001), G1005–G1012.
27. Wesselman, J.P., Kuijs, R., Hermans, J.J., Janssen, G.M., Fazzi, G.E., van Essen, H., Evelo, C.T., Struijker-Boudier, H.A., De Mey, J.G., Role of the Rhoa/Rho kinase system in flow-related remodeling of rat mesenteric small arteries in vivo. J. Vasc. Res. 41 (2004), 277–290.
28. Okada, Y., Galbreath, M.M., Shibata, S., Jarvis, S.S., Bivens, T.B., Vongpatanasin, W., Levine, B.D., Fu, Q., Morning blood pressure surge is associated with arterial stiffness and sympathetic baroreflex sensitivity in hypertensive seniors. Am. J. Physiol. Heart Circ. Physiol. 305 (2013), H793–H802, 10.1152/ajpheart.00254.2013.
29. O'Callaghan, E.L., McBryde, F.D., Burchell, A.E., Ratcliffe, L.E., Nicolae, L., Gillbe, I., Carr, D., Hart, E.C., Nightingale, A.K., Patel, N.K., Paton, J.F., Deep brain stimulation for the treatment of resistant hypertension. Curr. Hypertens. Rep., 16, 2014, 493, 10.1007/s11906-014-0493-1.
30. Kardos, A., Watterich, G., de Menezes, R., Csanády, M., Casadei, B., Rudas, L., Determinants of spontaneous baroreflex sensitivity in a healthy working population. Hypertension 37 (2001), 911–916.
31. 1-adrenoceptor reactivity in rat aortic smooth muscle. Eur. J. Pharmacol. 322 (1997), 201–210.
32. Shan, Z.Z., Dai, S.M., Su, D.F., Arterial baroreflex deficit induced organ damage in sinoaortic denervated rats. J. Cardiovasc. Pharmacol. 38 (2001), 427–437.
33. Ito, S., Komatsu, K., Tsukamoto, K., Sved, A.F., Tonic excitatory input to the rostral ventrolateral medulla in Dahl salt-sensitive rats. Hypertension 37 (2001), 687–691.
34. Weinstock, M., Schorer-Apelbaum, D., Impaired baroreflex sensitivity in the aetiology of salt hypertension in the rabbit. Clin. Sci. (Lond.) 68 (1985), 489–493.
35. Obias-Manno, D., Wijetunga, M., Risk stratification and primary prevention of sudden cardiac death: sudden death prevention. AACN Clin. Issues 15 (2004), 404–418.
36. Corkal, J.C., Palamarchuk, I., Kimpinski, K., Differences in cardiac autonomic function contributes to heart rate abnormalities in POTS and IST. Auton. Neurosci. 186 (2014), 85–90, 10.1016/j.autneu.2014.09.016.
37. El-Gowelli, H.M., Helmy, M.W., Ali, R.M., El-Mas, M.M., Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-beta1/IL-2/COX-2/endothelin ET(B) receptor cascade. Toxicol. Appl. Pharmacol. 275 (2014), 88–95.
38. Helmy, M.W., Helmy, M.M., El-Mas, M.M., Enhanced lipoxygenase/LTD4 activity accounts for the exaggerated hypertensive and nephrotoxic effects of cyclosporine plus indomethacin in rats. FASEB J., 31, 2017, lb54.
39. Chiu, P.J.S., Vemulapalli, S., Sabin, C., Rivelli, M., Bernardino, V., Sybertz, E.J., Sympathoadrenal stimulation, not endothelin, plays a role in acute pressor response to cyclosporine in anesthetized rats. J. Pharmacol. Exp. Ther. 261 (1992), 994–999.
40. El-Mas, M.M., Afify, E.A., Omar, A.G., Sharabi, F.M., Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control. J. Pharmacol. Exp. Ther. 301 (2002), 346–354.
41. Scherrer, U., Vissing, S.F., Morgan, B.J., Rollins, J.A., Tindall, R.S.A., Ring, S., Hanson, P., Mohanty, P.K., Victor, R.G., Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N. Engl. J. Med. 323 (1990), 693–699.
42. Ciarcia, R., Damiano, S., Florio, A., Spagnuolo, M., Zacchia, E., Squillacioti, C., Mirabella, N., Florio, S., Pagnini, U., Garofano, T., Polito, M.S., Capasso, G., Giordano, A., The protective effect of apocynin on cyclosporine A-induced hypertension and nephrotoxicity in rats. J. Cell. Biochem. 116 (2015), 1848–1856, 10.1002/jcb.25140.
43. Li, H., Hortmann, M., Daiber, A., Oelze, M., Ostad, M.A., Schwarz, P.M., Xu, H., Xia, N., Kleschyov, A.L., Mang, C., Warnholtz, A., Münzel, T., Förstermann, U., Cyclooxygenase 2-selective and nonselective nonsteroidal anti-inflammatory drugs induce oxidative stress by up-regulating vascular NADPH oxidases. J. Pharmacol. Exp. Ther. 326 (2008), 745–753, 10.1124/jpet.108.139030.
44. Santana-Filho, V.J., Davis, G.J., Castania, J.A., Ma, X., Salgado, H.C., Abboud, F.M., Fazan, R. Jr., Chapleau, M.W., Autocrine/paracrine modulation of baroreceptor activity after antidromic stimulation of aortic depressor nerve in vivo. Auton. Neurosci. 180 (2014), 24–31.
45. Rodriguez-Perez, A.I., Borrajo, A., Rodriguez-Pallares, J., Guerra, M.J., Labandeira-Garcia, J.L., Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation. Glia 63 (2015), 466–482, 10.1002/glia.22765.
46. Glick, G., Braunwald, E., Relative roles of the sympathetic and parasympathetic nervous system in the reflex control of heart rate. Circ. Res. 16 (1965), 363–375.
47. El-Mas, M.M., Afify, E.A., Mohy El-Din, M.M., Omar, A.G., Sharabi, F.M., Testosterone facilitates the baroreceptor control of reflex bradycardia: role of cardiac sympathetic and parasympathetic components. J. Cardiovasc. Pharmacol. 38 (2001), 754–763.
48. Hermann, M., Camici, G., Fratton, A., Hurlimann, D., Tanner, F.C., Hellermann, J.P., Fiedler, M., Thiery, J., Neidhart, M., Gay, R.E., Gay, S., Lüscher, T.F., Ruschitzka, F., Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension. Circulation 108 (2003), 2308–2311.
49. Courtois, E., Marques, M., Barrientos, A., Casado, S., López-Farré, A., Lead-induced downregulation of soluble guanylate cyclase in isolated rat aortic segments mediated by reactive oxygen species and cyclooxygenase-2. J. Am. Soc. Nephrol. 14 (2003), 1464–1470.
50. 2 in superoxidedismutase-induced enhancement of endothelium-dependent relaxation in rabbit mesenteric resistance artery. Br. J. Pharmacol. 139 (2003), 444–456.
51. Tavares, P., Reis, F., Ribeiro, C.A., Teixeira, F., Cardiovascular effects of cyclosporin treatment in an experimental model. Rev. Port. Cardiol. 21 (2002), 141–155.
52. Oriji, G.K., Keiser, H.R., Role of nitric oxide in cyclosporine A-induced hypertension. Hypertension 32 (1998), 849–855.
53. Nair, A.B., Jacob, S., A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7 (2016), 27–31.
54. Muscara, M.N., McKnight, W., Asfaha, S., Wallace, J.L., Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Br. J. Pharmacol. 129 (2000), 681–686.
55. Ibrahim, K.S., El-Yazbi, A.F., El-Gowelli, H.M., El-Mas, M.M., Opposite modulatory effects of selective and non-selective cyclooxygenase inhibition on cardiovascular and autonomic consequences of cyclosporine in female rats. Basic Clin. Pharmacol. Toxicol. 120 (2017), 571–581.
56. Wang, Y.X., Pang, C.C., Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. J. Pharmacol. Exp. Ther. 265 (1993), 263–272.